Do you see safety signals associated with ultra-aggressive LDL-C lowering and what is the role of PAD as a risk factor guiding LDL-C reduction?

Do you see safety signals associated with ultra-aggressive LDL-C lowering and what is the role of PAD as a risk factor guiding LDL-C reduction?

Do you see safety signals associated with ultra-aggressive LDL-C lowering and what is the role of PAD as a risk factor guiding LDL-C reduction?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical Cardiology, Interventional Cardiology, Lipid Medicine, Atherosclerosis and Diabetes Specialist's Perspective

Presenter

Stefano Del Prato, MD PhD

Stefano Del Prato, MD PhD

Professor of Endocrinology and Metabolism School of Medicine, University of Pisa Chief of the Section of Diabetes University of Pisa, Italy Clinical Associate Professor of Medicine University of Texas, San Antonio Health Science Center San Antonio, Texas